- Home
- ISPO vs DXR Comparison
ISPO vs DXR Comparison
Compare ISPO & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPO
- DXR
- Stock Information
- Founded
- ISPO 2010
- DXR 1970
- Country
- ISPO United States
- DXR United States
- Employees
- ISPO N/A
- DXR N/A
- Industry
- ISPO Blank Checks
- DXR Medical/Dental Instruments
- Sector
- ISPO Finance
- DXR Health Care
- Exchange
- ISPO Nasdaq
- DXR Nasdaq
- Market Cap
- ISPO 44.3M
- DXR 46.9M
- IPO Year
- ISPO N/A
- DXR N/A
- Fundamental
- Price
- ISPO $3.06
- DXR $11.00
- Analyst Decision
- ISPO
- DXR Strong Buy
- Analyst Count
- ISPO 0
- DXR 1
- Target Price
- ISPO N/A
- DXR $25.00
- AVG Volume (30 Days)
- ISPO 30.2K
- DXR 80.0K
- Earning Date
- ISPO 08-12-2025
- DXR 01-01-0001
- Dividend Yield
- ISPO N/A
- DXR N/A
- EPS Growth
- ISPO N/A
- DXR 86.16
- EPS
- ISPO N/A
- DXR 0.11
- Revenue
- ISPO $261,225,000.00
- DXR $119,714.00
- Revenue This Year
- ISPO N/A
- DXR N/A
- Revenue Next Year
- ISPO $148.66
- DXR N/A
- P/E Ratio
- ISPO N/A
- DXR $104.33
- Revenue Growth
- ISPO N/A
- DXR N/A
- 52 Week Low
- ISPO $2.19
- DXR $6.55
- 52 Week High
- ISPO $7.17
- DXR $11.41
- Technical
- Relative Strength Index (RSI)
- ISPO 51.97
- DXR 62.60
- Support Level
- ISPO $2.85
- DXR $10.01
- Resistance Level
- ISPO $3.18
- DXR $11.06
- Average True Range (ATR)
- ISPO 0.22
- DXR 0.62
- MACD
- ISPO 0.03
- DXR 0.02
- Stochastic Oscillator
- ISPO 65.67
- DXR 97.84
About ISPO Inspirato Incorporated
Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.